Antiretroviral Drugs

Gilead
Pharma

Gilead's bictegravir, lenacapavir tablet meets mark in phase 3

For people who are on multi-tablet HIV regimens, many of whom are also on drugs for other conditions, the findings are "significant," an expert said.
Eric Sagonowsky Nov 13, 2025 9:55am
Gilead

Gilead's PrEP shows early promise in once-yearly dosing

Mar 11, 2025 2:30pm
head to head against clash football helmets fight combat

GSK's Dovato matches Gilead's Biktarvy with less weight gain

Jul 23, 2024 4:00am
Blue Cross Blue Shield of NC removes HIV drugs from costly price tiers

WHO flags increasing resistance to GSK's Tivicay in 4 countries

Mar 6, 2024 2:02pm
GSK

GSK sees £7B in HIV sales by 2026, updates next-gen timelines

Sep 28, 2023 9:00am
Gilead

Gilead's twice-yearly HIV med snags first nod after FDA rebuff

Aug 22, 2022 10:25am